Related Experiment Videos
The argument for a combined cancer consortium research data base
Cancer
|October 1, 1985
Summary
Epidemiologic data on childhood brain tumors from the Surveillance Epidemiology End Results (SEER) registry reveal survival statistics from 1968-1979. Establishing a centralized database is crucial for improving pediatric brain tumor research and treatment strategies.
Area of Science:
- Pediatric Oncology
- Epidemiology
- Neuro-oncology
Background:
- Epidemiologic data on childhood brain tumors were analyzed using the Surveillance Epidemiology End Results (SEER) registry.
- Survival statistics for five major pediatric brain tumor types between 1968 and 1979 were examined.
- Comparisons were made between survival rates of patients treated in community versus university hospitals.
Purpose of the Study:
- To present epidemiologic and survival data for childhood brain tumors.
- To highlight limitations in current data collection, including lack of uniform reporting and pathologic confirmation.
- To advocate for a centralized database for childhood cancer consortiums to enhance research.
Main Methods:
- Analysis of SEER registry data for pediatric brain tumor cases diagnosed between 1968 and 1979.
- Comparison of survival statistics based on treatment setting (community vs. university hospitals).
- Identification of data limitations and areas for improvement in pediatric neuro-oncology research.
Main Results:
- Survival statistics for five major childhood brain tumor types were presented for the period 1968-1979.
- Differences in survival were noted between patients treated in community and university hospital settings.
- Significant limitations in data uniformity, pathologic confirmation, and patient cohort size were identified.
Conclusions:
- Current data collection methods for childhood brain tumors are insufficient for robust research.
- A centralized, standardized database is essential for addressing critical research questions in pediatric neuro-oncology.
- Improved data collection will facilitate the design of future studies, identify treatment effects, and potentially modify treatment programs for better outcomes.